MZTI Stock Analysis: The Marzetti | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 2.763m USD | 12M Return: -39.8% | US5138471033 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 45.8M
EPS Trend: 85.1%
Qual. Beats: 0
Rev. Trend: 95.4%
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Marzetti Company (NASDAQ: MZTI) is a U.S.-based specialty food manufacturer that operates through two segments: Retail and Foodservice. The company sells its products through sales personnel, food brokers, and distributors to retailers and restaurants, relying on a multi-channel go-to-market approach common within the consumer staples sector.
MZTIs brand portfolio spans frozen baked goods (New York Bakery, Sister Schuberts), salad dressings and dips (Marzetti, Cardinis, Girards), croutons and toppings (Chatham Village), and frozen pasta. In addition to owned brands, the company generates revenue through brand licensing agreements with major restaurant chains, including Olive Garden, Buffalo Wild Wings, Chick-fil-A, Texas Roadhouse, and Subway-a co-manufacturing and licensing model that is widely used in the packaged food industry to extend distribution without assuming direct retail marketing costs.
The company was founded in 1896 and is headquartered in Westerville, Ohio. It was previously known as Lancaster Colony Corporation before adopting the Marzetti Company name in June 2025, reflecting the growing prominence of the Marzetti brand within its portfolio.
- Olive Garden and Chick-fil-A licensing fuels foodservice segment growth
- Commodity input costs pressure gross margins across retail and foodservice
- Retail frozen bread and dressing volumes drive category growth
| Net Income: 175.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -3.77 > 1.0 |
| NWC/Revenue: 13.26% < 20% (prev 16.43%; Δ -3.17% < -1%) |
| CFO/TA 0.22 > 3% & CFO 283.8m > Net Income 175.8m |
| Net Debt (94.0m) to EBITDA (298.4m): 0.32 < 3 |
| Current Ratio: 2.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.5m) vs 12m ago 0.07% < -2% |
| Gross Margin: 24.19% > 18% (prev 23.87%; Δ 0.33% > 0.5%) |
| Asset Turnover: 154.3% > 50% (prev 154.0%; Δ 0.34% > 0%) |
| Interest Coverage Ratio: 130.2 > 6 (EBIT TTM 229.5m / Interest Expense TTM 1.76m) |
| A: 0.20 (Total Current Assets 443.6m - Total Current Liabilities 186.3m) / Total Assets 1.27b |
| B: 1.28 (Retained Earnings 1.63b / Total Assets 1.27b) |
| C: 0.18 (EBIT TTM 229.5m / Avg Total Assets 1.26b) |
| D: 3.61 (Book Value of Equity 998.5m / Total Liabilities 276.2m) |
| Altman-Z'' = 10.51 = AAA |
| DSRI: 0.95 (Receivables 95.8m/99.2m, Revenue 1.94b/1.91b) |
| GMI: 0.99 (GM 23.87% / 24.19%) |
| AQI: 1.04 (AQ_t 0.19 / AQ_t-1 0.18) |
| SGI: 1.02 (Revenue 1.94b / 1.91b) |
| TATA: -0.08 (NI 175.8m - CFO 283.8m) / TA 1.27b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of September 27, 2026, the stock is trading at USD 100.47 with a total of 350,741 shares traded. Over the past week, the price has changed by +0.55%, over one month by -13.55%, over three months by -9.75% and over the past year by -39.82%.
Current recommended Stop Loss: 96.10 (which is 4.3% or 1.3 ATR below the current price).
The Marzetti has no consensus analysts rating.
P/E Trailing = 14.5057
P/E Forward = 36.1011
P/S = 1.4318
P/B = 2.6694
P/EG = 3.1204
Revenue TTM = 1.94b USD
EBIT TTM = 229.5m USD
EBITDA TTM = 298.4m USD
Long Term Debt = 189.3m USD (from longTermDebt, last quarter)
Short Term Debt = 11.7m USD (from shortTermDebt, last quarter)
Debt = 255.5m USD (corrected: LT Debt 189.3m + ST Debt 11.7m) + Leases 54.5m
Net Debt = 94.0m USD (calculated: Debt 255.5m - CCE 161.5m)
Enterprise Value = 2.86b USD (2.76b + Debt 255.5m - CCE 161.5m)
Interest Coverage Ratio = 130.2 (Ebit TTM 229.5m / Interest Expense TTM 1.76m)
EV/FCF = 13.86x (Enterprise Value 2.86b / FCF TTM 206.1m)
FCF Yield = 7.21% (FCF TTM 206.1m / Enterprise Value 2.86b)
FCF Margin = 10.62% (FCF TTM 206.1m / Revenue TTM 1.94b)
Net Margin = 9.06% (Net Income TTM 175.8m / Revenue TTM 1.94b)
Gross Margin = 24.19% ((Revenue TTM 1.94b - Cost of Revenue TTM 1.47b) / Revenue TTM)
Gross Margin QoQ = 22.32% (prev 23.65%)
Tobins Q-Ratio = 2.24 (Enterprise Value 2.86b / Total Assets 1.27b)
Interest Expense / Debt = 0.69% (Interest Expense 1.76m / Debt 255.5m)
Taxrate = 22.18% (50.1m / 226.0m)
NOPAT = 178.6m (EBIT 229.5m * (1 - 22.18%))
Current Ratio = 2.38 (Total Current Assets 443.6m / Total Current Liabilities 186.3m)
Debt / Equity = 0.26 (Debt 255.5m / totalStockholderEquity, last quarter 998.5m)
Debt / EBITDA = 0.32 (Net Debt 94.0m / EBITDA 298.4m)
Debt / FCF = 0.46 (Net Debt 94.0m / FCF TTM 206.1m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.99% (Net Income 175.8m / Total Assets 1.27b)
RoE = 17.27% (Net Income TTM 175.8m / Total Stockholder Equity 1.02b)
RoCE = 19.01% (EBIT 229.5m / Capital Employed (Equity 1.02b + L.T.Debt 189.3m))
RoIC = 17.80% (NOPAT 178.6m / Invested Capital 1.00b)
WACC = 5.32% (E(2.76b)/V(3.02b) * Re(5.76%) + D(255.5m)/V(3.02b) * Rd(0.69%) * (1-Tc(0.22)))
Discount Rate = 5.76% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -34.58 | Cagr: 0.06%
[DCF] Terminal Value 73.10% ; FCFF base≈222.6m ; Y1≈195.2m ; Y5≈157.7m
[DCF] Fair Price = 89.30 (EV 2.53b - Net Debt 94.0m = Equity 2.44b / Shares 27.3m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 85.11 | EPS CAGR: 7.25% | SUE: 0.69 | # QB: 0
Revenue Correlation: 95.41 | Revenue CAGR: 1.82% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.38 | Chg30d=-22.47% | Revisions=-40% | Analysts=4
EPS next Quarter (2026-12-31): EPS=2.21 | Chg30d=-5.05% | Revisions=-40% | Analysts=4
EPS current Year (2027-06-30): EPS=6.73 | Chg30d=-6.47% | Revisions=-57% | GrowthEPS=-1.4% | GrowthRev=+4.8%
EPS next Year (2028-06-30): EPS=7.23 | Chg30d=-2.24% | Revisions=-25% | GrowthEPS=+7.4% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: -75% (up=0, down=9)